Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 10
|
pp. 4444–4464
Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma
Back to article
Figure 9
(9 of 10)
−
100%
+
Figure 9.
(
A
–
L
) Therapeutic drugs showed significant differences in IC50 between the high- and low-risk groups.
